Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects humans and animals which make coronavirus disease 2019 (COVID-19) a grievous epidemic worldwide which broke out in 2020. According to data analysis of the other coronavirus family, for instance severe acute respiratory...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhi-Mei, Yang, Ming-Hui, Yu, Kun, Lian, Zheng-Xing, Deng, Shou-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518217/
https://www.ncbi.nlm.nih.gov/pubmed/36188605
http://dx.doi.org/10.3389/fphar.2022.989664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518217/
https://www.ncbi.nlm.nih.gov/pubmed/36188605
http://dx.doi.org/10.3389/fphar.2022.989664

Ejemplares similares